Co-Authors
                                
                                
                                    This is a "connection" page, showing publications co-authored by Paolo Grossi and Carlo Tascini.
                                
                                
                                
                                    
                                        
                                                
    
        
        
        
            Connection Strength
            
                
            
            0.108
         
        
        
     
 
    
        
        - 
            The role of dalbavancin for Gram positive infections in the COVID-19 era: state of the art and future perspectives. Expert Rev Anti Infect Ther. 2021 09; 19(9):1125-1134.
            
            
                Score: 0.058
            
         
        
        - 
            Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience. Int J Antimicrob Agents. 2019 Apr; 53(4):408-415.
            
            
                Score: 0.050